Virtual screening of quinoline derived library for SARS-COV-2 targeting viral entry and replication

References

• Alexpandi, R., De Mesquita, J. F., Pandian, S. K., & Ravi, A. V. (2020). Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis. Frontiers in Microbiology, 11(July), 1796–1715. https://doi.org/10.3389/fmicb.2020.01796
   PubMedGoogle Scholar
• Barnard, R. A., Wittenburg, L. A., Amaravadi, R. K., Gustafson, D. L., Thorburn, A., & Thamm, D. H. (2014). Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma. Autophagy, 10(8), 1415–1425. https://doi.org/10.4161/auto.29165
   PubMed Web of Science ®Google Scholar
• Bhardwaj, V. K., Singh, R., Sharma, J., Rajendran, V., Purohit, R., & Kumar, S. (2020). Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/10.1080/07391102.2020.1766572
   Google Scholar
• Braga, S. F. P., Martins, L. C., da Silva, E. B., Sales Júnior, P. A., Murta, S. M. F., Romanha, A. J., Soh, W. T., Brandstetter, H., Ferreira, R. S., & de Oliveira, R. B. (2017). Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification. Bioorganic & Medicinal Chemistry, 25(6), 1889–1900. https://doi.org/10.1016/j.bmc.2017.02.009
   PubMed Web of Science ®Google Scholar
• Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., Li, X., Xia, J., Chen, N., Xiang, J., Yu, T., Bai, T., Xie, X., Zhang, L., Li, C., … Wang, C. (2020). A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. The New England Journal of Medicine, 382(19), 1787–1799. https://doi.org/10.1056/NEJMoa2001282
   PubMed Web of Science ®Google Scholar
• Chakraborty, H., & Bhattacharjya, S. (2020). Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics. Biophysical Chemistry, 265(June), 106438. https://doi.org/10.1016/j.bpc.2020.106438
   PubMedGoogle Scholar
• Chakraborty, C., Sharma, A. R., Bhattacharya, M., Sharma, G., Lee, S. S., & Agoramoorthy, G. (2020). COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients. Journal of Medical Virology, 92(11), 2260–2263. https://doi.org/10.1002/jmv.26078
   PubMed Web of Science ®Google Scholar
• Cheatham, T. E. I. I. I., Miller, J. L., Fox, T., Darden, T. A., & Kollman, P. A. (1995). Molecular dynamics simulations on solvated biomolecular systems: The particle mesh Ewald method leads to stable trajectories of DNA, RNA, and proteins. Journal of the American Chemical Society, 117(14), 4193–4194. https://doi.org/10.1021/ja00119a045
   Web of Science ®Google Scholar
• Chu, C. M., Cheng, V. C. C., Hung, I. F. N., Wong, M. M. L., Chan, K. H., Chan, K. S., Kao, R. Y. T., Poon, L. L. M., Wong, C. L. P., Guan, Y., Peiris, J. S. M., & Yuen, K. Y. (2004). Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax, 59(3), 252–256. https://doi.org/10.1136/thorax.2003.012658
   PubMed Web of Science ®Google Scholar
• Conti, P., Ronconi, G., Caraffa, A., Gallenga, C. E., Ross, R., Frydas, I., & Kritas, S. K. (2020). Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): Anti-inflammatory strategies. Journal of Biological Regulators and Homeostatic Agents, 34(2), 327–331. https://doi.org/10.23812/CONTI-E
   PubMed Web of Science ®Google Scholar
• Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., Li, C., Li, Y., Bai, F., Wang, H., Cheng, X., Cen, X., Hu, S., Yang, X., Wang, J., … Liu, H. (2020). Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science (New York, N.Y.), 368(6497), 1331–1335. https://doi.org/10.1126/science.abb4489
   PubMed Web of Science ®Google Scholar
• de Bruin, G., Demont, D., de Zwart, E., Verkaik, S., Hoogenboom, N., van de Kar, B., van Lith, B., Emmelot- van Hoek, M., Gulrajani, M., Covey, T., Kaptein, A., & Barf, T. (2020). Discovery of quinoline-based irreversible BTK inhibitors. Bioorganic & Medicinal Chemistry Letters, 30(14), 127261. https://doi.org/10.1016/j.bmcl.2020.127261
   PubMed Web of Science ®Google Scholar
• Desai, N. C., Patel, B. Y., Jadeja, K. A., Dave, B. P., & Desai, N. C. (2017). Nov appro drug des dev landscaping of quinoline based heterocycles as potential antimicrobial agents: A mini review. Mini Review, 1(4), 1–4. https://doi.org/10.19080/NAPDD.2017.01.555570
   Google Scholar
• Dror, R. O., Dirks, R. M., Grossman, J. P., Xu, H., & Shaw, D. E. (2012). Biomolecular Simulation: A Computational Microscope for Molecular Biology. Annual Review of Biophysics, 41(1), 429–452. https://doi.org/10.1146/annurev-biophys-042910-155245
   PubMed Web of Science ®Google Scholar
• Duan, L., Guo, X., Cong, Y., Feng, G., Li, Y., & Zhang, J. Z. H. (2019). Accelerated Molecular Dynamics Simulation for Helical Proteins Folding in Explicit Water. Frontiers in Chemistry, 7(August), 540–518. https://doi.org/10.3389/fchem.2019.00540
   PubMedGoogle Scholar
• Dutta, N. K., Mazumdar, K., & Gordy, J. T. (2020). The Nucleocapsid Protein of SARS–CoV-2: A Target for Vaccine Development. Journal of Virology, 94(13), 1–2. https://doi.org/10.1128/JVI.00647-20
   Web of Science ®Google Scholar
• Elfiky, A. A. (2020). SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/10.1080/07391102.2020.1761882
   Web of Science ®Google Scholar
• Elzupir, A. O. (2020). Inhibition of SARS-CoV-2 main protease 3CLpro by means of α-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking. Journal of Molecular Structure, 1222, 128878). https://doi.org/10.1016/j.molstruc.2020.128878
   PubMed Web of Science ®Google Scholar
• Hollingsworth, S. A., & Dror, R. O. (2018). Molecular dynamics simulation for all. Neuron, 99(6), 1129–1143. https://doi.org/10.1016/j.neuron.2018.08.011
   PubMed Web of Science ®Google Scholar
• Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5 https://doi.org/10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Joung, I. S., & Cheatham, T. E. (2008). Determination of Alkali and Halide Monovalent Ion Parameters for Use in Explicitly Solvated Biomolecular Simulations. The Journal of Physical Chemistry B, 112(30), 9020–9041. https://doi.org/10.1021/jp8001614
   PubMed Web of Science ®Google Scholar
• Kang, S., Yang, M., Hong, Z., Zhang, L., Huang, Z., Chen, X., He, S., Zhou, Z., Zhou, Z., Chen, Q., Yan, Y., Zhang, C., Shan, H., & Chen, S. (2020). Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. Acta Pharmaceutica Sinica. B, 10(7), 1228–1238. https://doi.org/10.1016/j.apsb.2020.04.009
   PubMed Web of Science ®Google Scholar
• Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 39(8), 2679–2692. https://doi.org/10.1080/07391102.2020.1753577
   Google Scholar
• Kiplin Guy, R., DiPaola, R. S., Romanelli, F., & Dutch, R. E. (2020). Rapid repurposing of drugs for COVID-19. Science (New York, N.Y.), 368(6493), 829–830. https://doi.org/10.1126/science.abb9332
   PubMed Web of Science ®Google Scholar
• Ko, W.-C., Rolain, J.-M., Lee, N.-Y., Chen, P.-L., Huang, C.-T., Lee, P.-I., & Hsueh, P.-R. (2020). Arguments in favour of remdesivir for treating SARS-CoV-2 infections. In International Journal of Antimicrobial Agents, 55 (4), 105933. https://doi.org/10.1016/j.ijantimicag.2020.105933
   PubMed Web of Science ®Google Scholar
• Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., & Wang, X. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature, 581(7807), 215–220. https://doi.org/10.1038/s41586-020-2180-5
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786. https://doi.org/10.1021/ci200227u
   PubMed Web of Science ®Google Scholar
• Law, P. K. (2020). COVID-19 Pandemic: Its Origin, Implications and Treatments. Open Journal of Regenerative Medicine, 09(02), 43–64. https://doi.org/10.4236/ojrm.2020.92006
   Google Scholar
• Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hu, Z., Zhong, W., & Wang, M. (2020). Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. In Cell Discovery. https://doi.org/10.1038/s41421-020-0156-0
   Google Scholar
• Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. https://doi.org/10.1021/acs.jctc.5b00255
   PubMed Web of Science ®Google Scholar
• Marella, A., Tanwar, O. P., Saha, R., Ali, M. R., Srivastava, S., Akhter, M., Shaquiquzzaman, M., & Alam, M. M. (2013). Quinoline: A versatile heterocyclic. Saudi Pharmaceutical Journal : SPJ : The Official Publication of the Saudi Pharmaceutical Society, 21(1), 1–12. https://doi.org/10.1016/j.jsps.2012.03.002
   PubMed Web of Science ®Google Scholar
• Onufriev, A., Bashford, D., & Case, D. A. (2000). Modification of the generalized born model suitable for macromolecules. The Journal of Physical Chemistry B, 104(15), 3712–3720. https://doi.org/10.1021/jp994072s
   Web of Science ®Google Scholar
• Ramser, B., Kokot, A., Metze, D., Weiss, N., Luger, T. A., & Böhm, M. (2009). Hydroxychloroquine modulates metabolic activity and proliferation and induces autophagic cell death of human dermal fibroblasts. The Journal of Investigative Dermatology, 129(10), 2419–2426. https://doi.org/10.1038/jid.2009.80
   PubMed Web of Science ®Google Scholar
• Roe, D. R., & Cheatham, T. E. (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Roschewski, M., Lionakis, M. S., Sharman, J. P., Roswarski, J., Goy, A., Monticelli, M. A., Roshon, M., Wrzesinski, S. H., Desai, J. V., Zarakas, M. A., Collen, J., Rose, K., Hamdy, A., Izumi, R., Wright, G. W., Chung, K. K., Baselga, J., Staudt, L. M., & Wilson, W. H. (2020). Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Science Immunology, 5(48), eabd0110. https://doi.org/10.1126/sciimmunol.abd0110
   PubMed Web of Science ®Google Scholar
• Roskoski, R. (2016). Ibrutinib inhibition of Bruton protein-tyrosine kinase (BTK) in the treatment of B cell neoplasms. Pharmacological Research, 113(Pt A), 395–408. https://doi.org/10.1016/j.phrs.2016.09.011
   PubMed Web of Science ®Google Scholar
• Rothan, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 109, 102433. https://doi.org/10.1016/j.jaut.2020.102433
   PubMed Web of Science ®Google Scholar
• Sachdeva, C., Wadhwa, A., Kumari, A., Hussain, F., Jha, P., & Kaushik, N. K. (2020). In silico Potential of Approved Antimalarial Drugs for Repurposing Against COVID-19. OMICS: A Journal of Integrative Biology, 24(10), 568–580. https://doi.org/10.1089/omi.2020.0071
   PubMed Web of Science ®Google Scholar
• Santhanam, V., Pant, P., Jayaram, B., & Ramesh, N. G. (2019). Design, synthesis and glycosidase inhibition studies of novel triazole fused iminocyclitol-δ-lactams. Organic & Biomolecular Chemistry, 17(5), 1130–1140. https://doi.org/10.1039/c8ob03084g
   PubMed Web of Science ®Google Scholar
• Shah, B., Modi, P., & Sagar, S. R. (2020). In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. Life Sciences, 252(March), 117652. https://doi.org/10.1016/j.lfs.2020.117652
   PubMedGoogle Scholar
• Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020). Cell entry mechanisms of SARS-CoV-2. Proceedings of the National Academy of Sciences, 117(21), 11727–11734. https://doi.org/10.1073/pnas.2003138117
   PubMed Web of Science ®Google Scholar
• Sureshkumar, B., Mary, Y. S., Panicker, C. Y., Suma, S., Armaković, S., Armaković, S. J., Van Alsenoy, C., & Narayana, B. (2020). Quinoline derivatives as possible lead compounds for anti-malarial drugs: Spectroscopic, DFT and MD study. Arabian Journal of Chemistry, 13(1), 632–648. https://doi.org/10.1016/j.arabjc.2017.07.006
   Web of Science ®Google Scholar
• Vanquelef, E., Simon, S., Marquant, G., Garcia, E., Klimerak, G., Delepine, J. C., Cieplak, P., & Dupradeau, F.-Y. (2011). R.E.D. Server: A web service for deriving RESP and ESP charges and building force field libraries for new molecules and molecular fragments. Nucleic Acids Res, 39(Web Server issue), W511–W517. https://doi.org/10.1093/nar/gkr288
   PubMedGoogle Scholar
• Vatansever, E. C., Yang, K., Kratch, K. C., Drelich, A., Cho, C.-C., Mellot, D. M., Xu, S., Tseng, C.-T K., & Liu, W. R. (2020). Targeting the SARS-CoV-2 main protease to repurpose drugs for COVID-19. bioRxiv: The preprint server for biology, https://doi.org/10.1101/2020.05.23.112235
   Google Scholar
• Yang, L., Skjevik, Å. A., Han Du, W. G., Noodleman, L., Walker, R. C., & Götz, A. W. (2016). Data for molecular dynamics simulations of B-type cytochrome c oxidase with the Amber force field. Data in Brief, 8, 1209–1214. https://doi.org/10.1016/j.dib.2016.07.043
   PubMed Web of Science ®Google Scholar
• Yin, W., Mao, C., Luan, X., Shen, D.-D., Shen, Q., Su, H., Wang, X., Zhou, F., Zhao, W., Gao, M., Chang, S., Xie, Y.-C., Tian, G., Jiang, H.-W., Tao, S.-C., Shen, J., Jiang, Y., Jiang, H., Xu, Y., … Xu, H. E. (2020). Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science (New York, N.Y.), 368(6498), 1499–1504. https://doi.org/10.1126/science.abc1560
   PubMed Web of Science ®Google Scholar